Wed, 05 Aug 2020 12:35:43 GMT
Regeneron tops Q2 profit estimates
On Wednesday, Regeneron Pharmaceuticals has topped its Q2 profit estimates, driven by robust sales of the eczema treatment Dupixent, as well as higher revenues related to its Sanofi and Bayer collaboration.